Who makes [18F]MK-6240?

[18F]MK-6240 is developed by Genentech, Inc..

Last reviewed 2026-04-19 · How we verify

[18F]MK-6240

Genentech, Inc. · Phase 3 active Small molecule

At a glance

Generic name	[18F]MK-6240
Sponsor	Genentech, Inc.
Modality	Small molecule
Phase	Phase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]MK-6240 CI brief — competitive landscape report
[18F]MK-6240 updates RSS · CI watch RSS
Genentech, Inc. portfolio CI